To develop a new drug product, a comprehensive team of experts is needed!

For NovoBioJect, alongside its 3 female co-founders, an international team of pharma industry veterans and KOLs make up Amplio Pharma's BoD, its supervisory board (Dutch Raad van Commissarissen), as well as a scientific and a strategic advisory board. 

 

"We firmly believe that with the current team, the effort to amplify the efficacy and safety of the cornerstone treatment of autoimmune diseases like rheumatoid arthritits, is in the most capable hands possible."

- M. Mensonides, co-founder and CEO Amplio Pharma BV